Lupin Ltd is the pharmaceutical company that has to foray into diagnostics to leverage its ‘doctor connect to tap a sector that has low entry barriers, gives high returns on capital employed, and is witnessing double-digit growth. A formal launch is expected next month, media reported.
- Transrail Lighting Bags Rs 459 Cr MENA Transmission Orders
- Kotak Mahindra Bank Hikes DCC Fee to 3.5% from August
- Jubilant Pharmova Arm Gets USFDA Nod for Antacid Drug
- TVS Motor Jumps 3.75% as NTORQ 125 Gets New Colours
- Fortis Healthcare Falls 2.25% as Delhi Govt Orders Probe
Lupin Diagnostics will be a part of Lupin Healthcare, a 100 per cent subsidiary of Lupin. It is in the process of recruiting the team, finalising franchise partners, and setting up a 45,000 square feet laboratory in Navi Mumbai.
Stock Covered in the news
Live
